The Safety of Incretin Therapy: Are Barriers Beginning to Fall?
The European Medicines Agency declared in July 2013 that there is no evidence that definitively links incretin-based therapy for type 2 diabetes and pancreatitis or pancreatic cancer. Today, August 2, 2013, there are rumors that the US FDA "concurs."
Source: Consultant Live - Category: Primary Care Source Type: news
More News: Cancer | Cancer & Oncology | Diabetes | Diabetes Type 2 | Endocrinology | European Medicines Agency (EMA) | Incretin Therapy | Pancreas | Pancreatic Cancer | Pancreatitis | Primary Care